propofol has been researched along with Chronic Kidney Failure in 24 studies
Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The primary objective of this study was to compare the pharmacokinetics of dexmedetomidine in patients with end-stage renal failure and secondary hyperparathyroidism with those in normal individuals." | 7.88 | Pharmacokinetics of dexmedetomidine administered to patients with end-stage renal failure and secondary hyperparathyroidism undergoing general anaesthesia. ( Huang, XH; Li, R; Li, Y; Liu, QW; Zhang, MZ; Zhang, Y; Zhong, W, 2018) |
| "PRIS causing hyperkalemia is a well-known clinical entity." | 5.43 | Propofol Induced Hyperkalemia and Its Management in End Stage Renal Disease Patients. ( El-Ali, IM; Onuchic, A; Trivedi, RD; Virmani, S, 2016) |
| "The primary objective of this study was to compare the pharmacokinetics of dexmedetomidine in patients with end-stage renal failure and secondary hyperparathyroidism with those in normal individuals." | 3.88 | Pharmacokinetics of dexmedetomidine administered to patients with end-stage renal failure and secondary hyperparathyroidism undergoing general anaesthesia. ( Huang, XH; Li, R; Li, Y; Liu, QW; Zhang, MZ; Zhang, Y; Zhong, W, 2018) |
| "We aim to describe management of a patient receiving renal transplantation for chronic renal failure due to Alport syndrome with low dose of intrathecal bupivacaine and continuous epidural infusion of local anesthetic." | 3.83 | Low-dose Spinal Block With Continuous Epidural Infusion for Renal Transplantation in a Patient With Alport Syndrome: A Case Report. ( Brazzi, L; Bretto, P; Donadio, PP; Gobbi, F; Sales, G, 2016) |
| "Results: ESRD patients receiving propofol TCI had significantly less reduction in blood pressure than those receiving sevoflurane inhalation (p < 0." | 3.11 | Application of Propofol Target-Controlled Infusion for Optimized Hemodynamic Status in ESRD Patients Receiving Arteriovenous Access Surgery: A Randomized Controlled Trial. ( Chen, PC; Chen, PN; Huang, TW; Lin, WC; Lu, IC; Lu, WL; Tse, J, 2022) |
| "Among the 2576 cases in ESRD patients, 1374 were in the TIVA group and 1202 were in the volatile group." | 3.01 | The influence of propofol-based total intravenous anesthesia on postoperative outcomes in end-stage renal disease patients: A retrospective observation study. ( Cho, HB; Chung, JW; Jang, YS; Kim, MG; Kim, SH; Lee, HK; Park, S; Park, SY; Song, S; Yoo, JH, 2021) |
| "The Ce values of propofol at the time of loss of consciousness were 4." | 1.62 | Potency of propofol for inducing loss of consciousness in end-stage kidney disease patients. ( Cho, HB; Chung, JW; Han, KS; Jun, MR; Kim, MG; Kim, SH; Park, JE; Park, SY; Song, S; Yoo, JH, 2021) |
| "PRIS causing hyperkalemia is a well-known clinical entity." | 1.43 | Propofol Induced Hyperkalemia and Its Management in End Stage Renal Disease Patients. ( El-Ali, IM; Onuchic, A; Trivedi, RD; Virmani, S, 2016) |
| "Propofol was administrated with our TCI system at the target blood concentration of 4 microg x ml(-1) for three hours." | 1.35 | [Evaluation of target-controlled infusion for propofol in patients with chronic renal failure undergoing living-related renal transplantation]. ( Igarashi, T; Ikeda, M; Iwakiri, H; Nagata, O; Ozaki, M, 2009) |
| "Rocuronium 0." | 1.33 | Pharmacodynamics of rocuronium 0.3 mg kg(-1) in adult patients with and without renal failure. ( De Boer, H; Driessen, JJ; Robertson, EN; Scheffer, GJ; Vogt, M, 2005) |
| "Propofol was administered through the Diprifusor TCI system (Astra Zeneca) with the target concentration of propofol for induction set at 3 micrograms/mL for group A patients and 2." | 1.32 | [Predictive capability of the TCI Diprifusor system in patients with terminal chronic renal insufficiency]. ( Baxarias Gascón, P; Queraltó Companyo, JM; Sabaté Tenas, S; Soler Corbera, J, 2003) |
| "Propofol was administered at 0." | 1.31 | Evaluation of induction doses of propofol: comparison between endstage renal disease and normal renal function patients. ( Goyal, P; Pandey, CK; Puri, GD; Srivastva, S, 2002) |
| "Atracurium is administered to ten chronic renal failure patients in the course of kidney transplantation, abiding to all requirements and doses recommended by the company." | 1.30 | [The use of atracurium besylate (Tracrium) in patients undergoing kidney transplantation]. ( Bovianska, N, 1997) |
| "Propofol conjugates were determined after hydrolysis with beta glucuronidase or HCl." | 1.29 | Pharmacokinetics of propofol and its conjugates after continuous infusion in normal and in renal failure patients: a preliminary study. ( Benevent, D; Debord, J; Dupuis, JL; Feiss, P; Lachatre, G; Lagarde, M; Narcisse, F; Nathan, N, 1993) |
| "In the chronic renal failure group not undergoing regular hemodialysis (n = 9), unbound propofol was 0." | 1.29 | Serum protein binding of propofol in patients with renal failure or hepatic cirrhosis. ( Calvo, R; Carlos, R; Costela, JL; Jiménez, R; Suárez, E, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (29.17) | 18.2507 |
| 2000's | 9 (37.50) | 29.6817 |
| 2010's | 5 (20.83) | 24.3611 |
| 2020's | 3 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, PN | 1 |
| Lu, IC | 1 |
| Huang, TW | 1 |
| Chen, PC | 1 |
| Lin, WC | 1 |
| Lu, WL | 1 |
| Tse, J | 1 |
| Cho, HB | 2 |
| Kim, MG | 2 |
| Park, SY | 2 |
| Song, S | 2 |
| Jang, YS | 1 |
| Park, S | 1 |
| Lee, HK | 1 |
| Yoo, JH | 2 |
| Chung, JW | 2 |
| Kim, SH | 2 |
| Jun, MR | 1 |
| Han, KS | 1 |
| Park, JE | 1 |
| Zhong, W | 1 |
| Zhang, Y | 1 |
| Zhang, MZ | 1 |
| Huang, XH | 1 |
| Li, Y | 1 |
| Li, R | 1 |
| Liu, QW | 1 |
| Virmani, S | 1 |
| Onuchic, A | 1 |
| El-Ali, IM | 1 |
| Trivedi, RD | 1 |
| Kumar, G | 1 |
| Gobbi, F | 1 |
| Sales, G | 1 |
| Bretto, P | 1 |
| Donadio, PP | 1 |
| Brazzi, L | 1 |
| Kocabas, S | 1 |
| Yedicocuklu, D | 1 |
| Askar, FZ | 1 |
| Igarashi, T | 1 |
| Nagata, O | 1 |
| Iwakiri, H | 1 |
| Ikeda, M | 1 |
| Ozaki, M | 1 |
| Goyal, P | 1 |
| Puri, GD | 1 |
| Pandey, CK | 1 |
| Srivastva, S | 1 |
| Sabaté Tenas, S | 1 |
| Soler Corbera, J | 1 |
| Queraltó Companyo, JM | 1 |
| Baxarias Gascón, P | 1 |
| Kakinohana, M | 1 |
| Tokumine, J | 1 |
| Kawashima, S | 1 |
| Koja, H | 1 |
| Sugahara, K | 1 |
| Tatebayashi, S | 1 |
| Imai, Y | 1 |
| Ohgi, K | 1 |
| Tamaki, S | 1 |
| Yamamoto, K | 1 |
| Takahashi, M | 1 |
| Kurehara, K | 1 |
| Furuya, H | 1 |
| Kirita, T | 1 |
| Robertson, EN | 1 |
| Driessen, JJ | 1 |
| Vogt, M | 1 |
| De Boer, H | 1 |
| Scheffer, GJ | 1 |
| Wang, YC | 1 |
| Liu, BM | 1 |
| Supernaw, RB | 1 |
| Lu, YH | 1 |
| Lee, PY | 1 |
| Honda, A | 1 |
| Arai, T | 1 |
| Akiyama, M | 1 |
| Masuda, E | 1 |
| Kobayashi, M | 1 |
| Hoka, S | 1 |
| Lee, SM | 1 |
| Kim, GH | 1 |
| Lee, JJ | 1 |
| Kim, JA | 1 |
| Choi, SJ | 1 |
| Kim, GS | 1 |
| Jung, HH | 1 |
| Nathan, N | 1 |
| Debord, J | 1 |
| Narcisse, F | 1 |
| Dupuis, JL | 1 |
| Lagarde, M | 1 |
| Benevent, D | 1 |
| Lachatre, G | 1 |
| Feiss, P | 1 |
| Costela, JL | 1 |
| Jiménez, R | 1 |
| Calvo, R | 1 |
| Suárez, E | 1 |
| Carlos, R | 1 |
| Bovianska, N | 1 |
| Kurokawa, S | 1 |
| Taga, K | 1 |
| Tobita, T | 1 |
| Kitahara, Y | 1 |
| Fukuda, S | 1 |
| Shimoji, K | 1 |
| Ickx, B | 1 |
| Cockshott, ID | 1 |
| Barvais, L | 1 |
| Byttebier, G | 1 |
| De Pauw, L | 1 |
| Vandesteene, A | 1 |
| D'Hollander, AA | 1 |
| Dahaba, AA | 1 |
| von Klobucar, F | 1 |
| Rehak, PH | 1 |
| List, WF | 1 |
| Yamauchi, M | 1 |
| Igarashi, M | 1 |
| Tsunoda, K | 1 |
| Edanaga, M | 1 |
| Suzuki, H | 1 |
| Tohdoh, Y | 1 |
| Namiki, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Comparative Study of Sevoflurane Sedation With TCI Propofol Sedation in Dialysis Dependent End Stage Renal Failure Patients for Transposition of Brachiocephalic Fistula Repair[NCT04839536] | Phase 4 | 36 participants (Anticipated) | Interventional | 2021-04-01 | Not yet recruiting | ||
| Evaluation of Duration of Curarisation (Surgical Efficacy) and Pharmacokinetics of Neuromuscular Block After a Single Dose of Rocuronium in Geriatric Patients (Age ≥ 80 Years ) Compared to a Younger Population (Age < 50 Years).[NCT03551652] | 28 participants (Anticipated) | Observational | 2020-05-15 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 trials available for propofol and Chronic Kidney Failure
| Article | Year |
|---|---|
Application of Propofol Target-Controlled Infusion for Optimized Hemodynamic Status in ESRD Patients Receiving Arteriovenous Access Surgery: A Randomized Controlled Trial.
Topics: Anesthesia, Inhalation; Anesthetics, Intravenous; Hemodynamics; Humans; Kidney Failure, Chronic; Pai | 2022 |
The influence of propofol-based total intravenous anesthesia on postoperative outcomes in end-stage renal disease patients: A retrospective observation study.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, Intravenous; Female; Heart Diseases; Humans; Incidence; | 2021 |
Propofol infusion for induction and maintenance of anaesthesia in patients with end-stage renal disease.
Topics: Adult; Anesthesia Recovery Period; Anesthesia, Intravenous; Anesthetics, Intravenous; Consciousness; | 1998 |
[Cardiovascular responses during laryngeal mask airway insertion in normotensive, hypertensive and chronic renal failure patients].
Topics: Adult; Aged; Anesthesia, Intravenous; Anesthetics, Intravenous; Hemodynamics; Humans; Hypertension; | 1999 |
20 other studies available for propofol and Chronic Kidney Failure
| Article | Year |
|---|---|
Potency of propofol for inducing loss of consciousness in end-stage kidney disease patients.
Topics: Aged; Anesthesia, Epidural; Anesthesia, Intravenous; Anesthetics, Intravenous; Consciousness; Dose-R | 2021 |
Pharmacokinetics of dexmedetomidine administered to patients with end-stage renal failure and secondary hyperparathyroidism undergoing general anaesthesia.
Topics: Adult; Anesthesia, General; Case-Control Studies; Dexmedetomidine; Female; Half-Life; Humans; Hyperp | 2018 |
Propofol Induced Hyperkalemia and Its Management in End Stage Renal Disease Patients.
Topics: Anesthetics, Intravenous; Arrhythmias, Cardiac; Electrocardiography; Heart Arrest; Humans; Hyperkale | 2016 |
Propofol as a Cause of Recurrent Pancreatitis in A Child with ESRD; A Cautionary Tale.
Topics: Anesthetics, Intravenous; Child; Female; Humans; Kidney Failure, Chronic; Pancreatitis; Propofol; Re | 2019 |
Low-dose Spinal Block With Continuous Epidural Infusion for Renal Transplantation in a Patient With Alport Syndrome: A Case Report.
Topics: Adult; Analgesia, Epidural; Anesthesia, Epidural; Anesthesia, General; Anesthesia, Spinal; Anestheti | 2016 |
The neuromuscular effects of 0.6 mg kg(-1) rocuronium in elderly and young adults with or without renal failure.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Androstanols; Anesthetics, Intravenous; Female; Humans; | 2008 |
[Evaluation of target-controlled infusion for propofol in patients with chronic renal failure undergoing living-related renal transplantation].
Topics: Adult; Anesthesia, General; Anesthetics, Intravenous; Female; Humans; Infusions, Intravenous; Kidney | 2009 |
Evaluation of induction doses of propofol: comparison between endstage renal disease and normal renal function patients.
Topics: Adult; Anesthesia Recovery Period; Anesthesia, Intravenous; Anesthetics, Intravenous; Case-Control S | 2002 |
[Predictive capability of the TCI Diprifusor system in patients with terminal chronic renal insufficiency].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anesthetics, Intravenous; Dose-Response Relationship, Dr | 2003 |
Patient-controlled sedation using propofol in eight patients with endstage renal failure.
Topics: Adult; Aged; Arteriovenous Shunt, Surgical; Conscious Sedation; Female; Hemodynamics; Humans; Hypnot | 2004 |
[The influence of intermittent hemodialysis (HD) on bispectral index (scale) (BIS) and serum propofol concentration under postoperative intravenous sedation].
Topics: Anesthesia, General; Anesthetics, Intravenous; Gingival Neoplasms; Heart Rate; Humans; Hypnotics and | 2004 |
Pharmacodynamics of rocuronium 0.3 mg kg(-1) in adult patients with and without renal failure.
Topics: Adult; Androstanols; Anesthesia, Intravenous; Anesthetics, Intravenous; Female; Humans; Intubation, | 2005 |
Management of star fruit-induced neurotoxicity and seizures in a patient with chronic renal failure.
Topics: Aged, 80 and over; Anesthetics, Intravenous; Anticonvulsants; Coma; Fatal Outcome; Female; Fruit; Hu | 2006 |
Anesthetic management of a patient with a history of Batista procedure for dilated cardiomyopathy undergoing gastric surgery.
Topics: Anesthesia, Epidural; Anesthesia, General; Anesthetics, Intravenous; Anesthetics, Local; Bupivacaine | 2006 |
Does propofol and alfentanil-induced sedation cause periodic apnoea in chronic renal failure patients?
Topics: Alfentanil; Anesthetics, Combined; Anesthetics, Intravenous; Apnea; Case-Control Studies; Female; Hu | 2010 |
Pharmacokinetics of propofol and its conjugates after continuous infusion in normal and in renal failure patients: a preliminary study.
Topics: Adult; Aged; Chromatography, High Pressure Liquid; Female; Glucuronidase; Half-Life; Humans; Hydroly | 1993 |
Serum protein binding of propofol in patients with renal failure or hepatic cirrhosis.
Topics: Adult; Anesthetics, Intravenous; Bilirubin; Blood Proteins; Chromatography, High Pressure Liquid; Cr | 1996 |
[The use of atracurium besylate (Tracrium) in patients undergoing kidney transplantation].
Topics: Anesthetics, Intravenous; Atracurium; Humans; Kidney Failure, Chronic; Kidney Transplantation; Neuro | 1997 |
[Anesthetic management for pericardial fenestration in a hypertrophic cardiomyopathy (HCM) patient with massive pericardial effusion].
Topics: Aged; Anesthesia, Intravenous; Anesthetics, Combined; Anesthetics, Intravenous; Atrial Fibrillation; | 1999 |
Total intravenous anesthesia with remifentanil, propofol and cisatracurium in end-stage renal failure.
Topics: Adult; Anesthesia, Intravenous; Anesthetics, Intravenous; Atracurium; Female; Hemodynamics; Humans; | 1999 |